Subsequent Events

6 Months Ended

Jun. 30, 2011

Subsequent Events

Subsequent Events

14. Subsequent Events

On July 27, 2011, the Company entered into a collaboration and license agreement with Depomed, Inc. (“Depomed”) in which it has licensed the rights to Depomed’s AcuformTM gastric retentive drug delivery technology. In connection with entering into the agreement, the Company will make an up-front payment to Depomed. The Company will also fund full-time equivalents of certain of Depomed’s development activities, and could make certain milestone and royalty payments pending the achievement of certain development and commercialization milestones.